Yahoo! Finance Search - Finance Home - Yahoo! - Help

Tuesday, March 31 2015 2:48am ET - U.S. Markets open in 6 hours and 42 minutes.
Industry Center - Drug Manufacturers - Major
Industry Center > Drug Manufacturers - Major > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
· REIT - Retail
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drug Manufacturers - Major News
Latest News
Monday, Mar 30, 2015
·Harwood Feffer LLP Announces Investigation of Auspex Pharmaceuticals, Inc.
PR Newswire - Mon 8:00 pm ET
·J&J, Glaxo settle U.S. lawsuit over allergy ads
at Fortune - Mon 6:36 pm ET
·J&J, Glaxo settle U.S. lawsuit over allergy ads
Reuters - Mon 6:07 pm ET
·What Products Affect Pfizer’s Revenue?
- Mon 6:06 pm ET
·Final Glance: Pharmaceuticals companies
AP - Mon 5:56 pm ET
·Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Auspex Pharmaceuticals, Inc. Stockholders
Business Wire - Mon 5:40 pm ET
·SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Auspex Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information
Business Wire - Mon 5:32 pm ET
·Amgen loses another round in its battle to fend off a biosimilar rival
at MarketWatch - Mon 5:06 pm ET
·Connecticut Bans State-Funded Travel to Indiana Over Religious Freedom Law
at The Wall Street Journal Online - Mon 5:00 pm ET
·​Teva Pharmaceutical to buy drug maker Auspex
at - Mon 5:00 pm ET
·Amgen Loses Another Round in its Battle to Fend Off a Biosimilar Rival
at The Wall Street Journal Online - Mon 4:57 pm ET
·Auspex Pharma Stockholders Encouraged to Contact Securities Law Firm about Takeover
PR Newswire - Mon 4:26 pm ET
·Raptor Pharmaceutical Announces Proposed Public Offering of Common Stock
GlobeNewswire - Mon 4:20 pm ET
·Aoxing Pharmaceutical Company, Inc. Receives GMP Certification
- Mon 4:15 pm ET
·AUSPEX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Believe the Acquisition by Teva Pharmaceutical Industries Ltd. May be Unfair to Shareholders
Business Wire - Mon 4:15 pm ET
·Teva Set for More Buys After Auspex
at - Mon 2:55 pm ET
·Nigerian Elections Extended Amid Glitches, Disruptions
at MarketWatch - Mon 2:29 pm ET
·Biopharmaceutical Business: Why It’s Important for Pfizer
- Mon 2:06 pm ET
·Are Auspex Shareholders Getting Enough in the Buyout?
- Mon 1:50 pm ET
·Midday Glance: Pharmaceuticals companies
AP - Mon 1:16 pm ET
More Latest News...
Sponsor Results
Pharma Marketing Company
Humanize Your Image & Increase ROI. Let's Talk About Pharma Marketing.
$5,730 College Grant
Get Degree 100% Online University or College Grant if Qualify. Act Now.
Neuroflexyn Brain Booster
Rated #1 Brain Booster Supplement. Achieve Ultimate Productivity.
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Manufacturers - Major Headlines
More Finance RSS Feeds

Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2015, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?